Jean‐Michel Bidart

Medicine · Health Sciences

39h-index4.5kcitations142works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(24), Hypothalamic control of reproductive hormones(21), Thyroid Cancer Diagnosis and Treatment(19), Thyroid Disorders and Treatments(12), Glycosylation and Glycoproteins Research(11)

Publications142 total

Supplementary Tables S1-S5 from Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models
2023Open Access
Supplementary Tables S1-S5 from Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models
2023Open Access
Data from Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models
2023Open Access
Data from Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models
2023Open Access
Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer
British Journal of Cancer·2016· 11 citedOpen Access
Abstract 5343: The effect of horizontal and vertical inhibition of nodes within the MAPK and PI3K-AKT pathways in NSCLC models
Cancer Research·2015· 1 cited
Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model
Annals of Oncology·2015· 27 citedOpen Access
NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation
Proceedings of the National Academy of Sciences·2015· 132 citedOpen Access
Follicular Thyroid Tumors
2014
Follicular Thyroid Tumors
2014Open Access
Changes in Signaling Pathways Induced by Vandetanib in a Human Medullary Thyroid Carcinoma Model, as Analyzed by Reverse Phase Protein Array
Thyroid·2013· 8 cited
Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop
Tumor Biology·2013· 30 citedOpen Access
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by Reverse Phase Protein Array.
Thyroid·2013
Abstract 3358: Pharmacokinetic investigation of unbound vandetanib in patients with medullary thyroid carcinoma using liquid chromatography-tandem mass spectrometry.
Cancer Research·2013
Iodide transporters expression in early human invasive trophoblast
Placenta·2012· 15 cited
Abstract 3757: CR8, a novel CDK inhibitor, enhances vandetanib activity in a human medullary thyroid carcinoma model
Cancer Research·2012
Abstract 3569: Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model as detected by reverse phase protein arrays
Cancer Research·2011
Abstract 5471: Pharmacokinetic investigation of vandetanib in patients with medullary thyroid carcinoma using liquid chromatography-tandem mass spectrometry
Cancer Research·2011
Hes1 Is Required for Appropriate Morphogenesis and Differentiation during Mouse Thyroid Gland Development
PLoS ONE·2011· 44 citedOpen Access
Follicular Thyroid Tumors
2011
page 1 of 8Next →

Frequent Co-authors

Claude Bohuon(14), Bernard Caillou(11), Dominique Bellet(11), Martin Schlumberger(10), Ludovic Lacroix(10), Frédéric Troalen(10), Monique Talbot(9), Martin Schlumberger(6), Corinne Dupuy(5), Steven Birken(5), Ulf‐Håkan Stenman(5), Éric Baudin(4), Catharine M. Sturgeon(4), Maria Nocera(4), Roland Salesse(4), Alain Puisieux(4), George R. Bousfield(4), Alain Virion(3), Catherine Lhommé(3), Claire Magnon(3)